Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 362 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Electrocardiogram (ECG) Clear all

Conditions: Healthy
Interventions: Consumer-facing wearable smart watch; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 292 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Atrial Fibrillation
Interventions: Electrocardiogram; Diagnostic Test
Lead sponsor: Garmin International; Industry
Eligibility: 22 Years and older
Enrollment: 568 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 6
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Saint Paul, Minnesota + 3 more

Conditions: Epilepsy
Interventions: ProGuardian; Device
Lead sponsor: Cyberonics, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 6
States / cities: Chicago, Illinois • Charlotte, North Carolina • Austin, Texas + 2 more

Conditions: Atrial Fibrillation
Interventions: Electrocardiogram recording; Device
Lead sponsor: Withings; Industry
Eligibility: 22 Years and older
Enrollment: 685 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 9
States / cities: Boca Raton, Florida • Hialeah, Florida • Miami, Florida + 6 more

Conditions: Atrial Fibrillation
Interventions: Standard Care; Other
Lead sponsor: Danbury Hospital; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Danbury, Connecticut

Conditions: Medical Oncology
Interventions: Anetumab ravtansine (BAY94-9343), Itraconazole; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 5
States / cities: Santa Monica, California • Detroit, Michigan • St Louis, Missouri + 2 more

Conditions: Vagus Nerve Stimulation
Interventions: Multi-Electrode Array (MEA) Recording; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Healthy
Interventions: LX4211 800 mg, LX4211 2000 mg, moxifloxacin 400 mg, LX4211 Placebo; Drug
Lead sponsor: Lexicon Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
Interventions: Obinutuzumab, Prednisone, Lenalidomide, Venetoclax, Ibrutinib, Acetaminophen, Diphenhydramine, Peg-filgrastim, CT Scan (chest, abdomen, and pelvis), MRI, 18f-FDG-PET, PET, Lumbar puncture/Ommaya tap, Bone marrow aspiration/biopsy, EKG; Drug · Other · Diagnostic Test + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Implantable Defibrillator User
Interventions: Not listed
Lead sponsor: Larisa Tereshchenko; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atrial Fibrillation
Interventions: Electrocardiogram; Diagnostic Test
Lead sponsor: Fitbit LLC; Industry
Eligibility: 22 Years and older
Enrollment: 472 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 9
States / cities: Washington D.C., District of Columbia • Orlando, Florida • The Villages, Florida + 6 more

Conditions: Neuroblastoma, Cancer
Interventions: Biopsy, Next Generation Sequencing, Tumor Scans, Bone marrow Tests, Physical Exam, Eye Exam, Labs, Pregnancy Test, Interviews, ECG, Echocardiogram, Ribociclib, Ceritinib; Procedure · Genetic · Other + 2 more
Lead sponsor: Yael P Mosse; Other
Eligibility: 1 Year to 21 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiac Arrest
Interventions: Echocardiography, Electrocardiogram (ECG); Diagnostic Test
Lead sponsor: Romolo Gaspari; Other
Eligibility: 18 Years and older
Enrollment: 813 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Hartford, Connecticut • Lebanon, New Hampshire • Stony Brook, New York + 3 more

Conditions: SLE, Lupus, Systemic Lupus Erthematosus, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)
Interventions: Physical examination, Electrocardiogram, SF-36 questionnaire, Clinical laboratory evaluations - Serology, Clinical laboratory evaluations - Biochemistry, Clinical laboratory evaluations - Hematology, Pregnancy Test, Urinalysis, SLE activity evaluation, SLE biomarker profiling, Cytokines and chemokine profiling, single dose of UC-MSCs, PROMIS instruments; Diagnostic Test · Other · Biological
Lead sponsor: LiveKidney.Bio; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Electrocardiogram
Interventions: Electrocardiogram; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Stanford, California

Conditions: Atrial Fibrillation
Interventions: Procainamide; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: QT Interval
Interventions: Telotristat etiprate, Placebo, Moxifloxacin; Drug
Lead sponsor: Lexicon Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2014
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Sickle Cell Disease
Interventions: Deferoxamine, Deferasirox, Deferiprone, Echocardiography, Electrocardiogram (ECG); Drug · Device
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Fairfax, Virginia • Falls Church, Virginia

Conditions: Healthy
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 8 Years to 21 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Multiple Myeloma, Heart Disease Risk Factors
Interventions: Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway; Other
Lead sponsor: University of Vermont Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Anemia
Interventions: ferumoxytol, moxifloxacin, placebo; Drug
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 5,115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1985 – 2006
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Focus: Adult Subjects Who Require PICC Placement
Interventions: ECG-guided PICC placement; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Malignant Neoplasms of Independent (Primary) Multiple Sites
Interventions: Tongue Assessment, Stool Sample, Questionnaires, Holter Monitor, Yogurt; Other · Behavioral · Device
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Wearable Technology in Endoscopy

Electrocardiogram Clinical Validation Study

Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data

Withings ECG-app Study

Risk Factors That Contribute to the Maintenance of Sinus Rhythm

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Recording Cutaneous Vagal Nerve Activity With Multi-Electrode Array (MEA) in Patients Undergoing VNS Therapy

Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System

Assessment of S-ICD Eligibility With 12-Lead ECG

Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch

Next Generation Personalized Neuroblastoma Therapy

Vfib by ECG or Echo During Cardiac Arrest

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

Surface ECG Mapping

ST-segment Elevation as an AF Endophenotype

A Thorough QT Study of Telotristat Etiprate

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Cardiovascular Magnetic Resonance Imaging of Pediatric Normal Volunteers

MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma

A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women

Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age

Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms